Genomic Health Inc
(GHDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 27,783 | 23,440 | 19,348 | 15,901 | 14,690 |
| Cost of Goods | 6,850 | 5,884 | 4,914 | 4,398 | 4,172 |
| Gross Profit | 20,933 | 17,556 | 14,434 | 11,503 | 10,518 |
| Operating Expenses | 26,224 | 25,562 | 22,095 | 20,013 | 18,322 |
| Operating Income | -4,441 | -7,122 | -6,747 | -8,112 | -7,632 |
| Interest Expense | 106 | 133 | 143 | 162 | 178 |
| Other Income | 448 | 621 | 899 | 1,021 | 612 |
| Pre-tax Income | -4,099 | -6,634 | -5,991 | -7,253 | -7,198 |
| Net Income Continuous | -4,099 | -6,634 | -5,991 | -7,253 | -7,198 |
| Net Income | $-4,099 | $-6,634 | $-5,991 | $-7,253 | $-7,198 |
| EPS Basic Total Ops | -0.15 | -0.24 | -0.20 | -0.26 | -0.28 |
| EPS Basic Continuous Ops | -0.15 | -0.24 | -0.21 | -0.26 | -0.28 |
| EPS Diluted Total Ops | -0.15 | -0.24 | -0.20 | -0.26 | -0.28 |
| EPS Diluted Continuous Ops | -0.15 | -0.24 | -0.21 | -0.26 | -0.28 |
| EBITDA(a) | $-3,257 | $-6,086 | $-5,535 | $-7,092 | $-6,787 |